Janux Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-14.6M | $7.8M |
| FY2021 | — | $366.3M | $35.6M |
| FY2022 | — | $320.7M | $51.4M |
| FY2023 | — | $344.3M | $19.2M |
| FY2024 | — | $1.02B | $430.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-14.6M | $7.8M |
| FY2021 | — | $366.3M | $35.6M |
| FY2022 | — | $320.7M | $51.4M |
| FY2023 | — | $344.3M | $19.2M |
| FY2024 | — | $1.02B | $430.6M |